OOIR: Observatory of International Research

Papers

(The H4-Index of Current Neuropharmacology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome	127
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS	108
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction	100
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder	94
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease	93
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury	90
Childhood Trauma and Self-harm in Youths with Bipolar Disorders	89
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats	83
Neurobiological Mechanisms Underlying Hippocampal Dysfunction in Post-Traumatic Stress Disorder	65
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 2017	65
Role of Glycerophospholipid Metabolism in Epilepsy	63
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study	62
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring	60
The Role of Natural Products in Treatment of Depressive Disorder	60
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential	59
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)	58
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management	58
Meet the Editorial Board Member	57
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis	55
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy	54
Antioxidants, Hormetic Nutrition, and Autism	53
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases	49
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics	48
Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain	48
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase	48

Unraveling the Role of Perivascular Macrophages in Alzheimer's Disease: Insights from the Crosstalk between Immunometabolism and Ferroptosis	46
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation	46
Myeloid-derived Suppressor Cells and Multiple Sclerosis	43
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's	43
Role of Traditional Chinese Medicine Formulations in Reducing Neuroinflammation and Oxidative Stress in Alzheimer’s Disease	40
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study	39
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials	39
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development	37
Repetitive Transcranial Magnetic Stimulation Alters Brain Communication Networks to Improve the Cognitive Function in Patients with Amnestic Mild Cognitive Impairment - A Clinical Trial	37
What is the Role of Lithium in Epilepsy?	37
Recent Advances in Guillain-Barré Syndrome: Neurological Disorder, Pathophysiology, Diagnosis, Treatment, and Challenges	35